研究：業績

【2013】原著（英文）

• Ohishi M, Yamamoto K, Rakugi H.
• Angiotensin (1-7) and other Angiotensin Peptides.
  Current Pharmaceutical Design 2013; 19: 3060-3064.
• Takeuchi K, Yamamoto K, Ohishi M, Takeshita H, Hongyo K, Kawai T, Takeda M, Kamide K, Kurtz TW, and Rakugi H.
• Telmisartan modulates mitochondrial function in vascular smooth muscle cells.
  Hypertension Research 2013; 36: 433-439.
• Kamide K, Asayama K, Katsuya T, Ohkubo T, Hirose T, Inoue R, Metoki H, Kikuya M, Obara T, Hanada H, Thijs L, Kuznetsova T, Noguchi Y, Sugimoto K, Ohishi M, Morimoto S, Nakahashi T, Takiuchi S, Ishimitsu T, Tsuchihashi T, Soma M, Higaki J, Matsuura H, Shinagawa T, Sasaguri T, Miki T, Takeda K, Shimamoto K, Ueno M, Hosomi N, Kato J, Komai N, Kojima S, Sase K, Miyata T, Tomoike H, Kawano Y, Ogihara T, Rakugi H, Staessen JA, Imai Y.
• Genome-Wide Pharmacogenomic Response to antihypertensive medication using home blood pressure measurements: a pilot study nested within the HOMED-BP Study.
  Pharmacogenomics 2013; 14: 1709-1721.
• Ohishi M, Kawai T, Hayashi N, Kitano S, Katsuya T, Nagano M, Hirotani A, Yamamoto K, Kamide K, Rakugi H.
• Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: The Cotalo study.
  Hypertens Res 2013; 36: 620-626.
• Kawai T, Ohishi M, Ito N, Onishi M, Takeya Y, Yamamoto K, Kamide K, Rakugi H.
• Alteration of Vascular Function is Important Factor in the Correlation between Visit-to-visit Variability in Blood Pressure and Cardiovascular Disease.
  J Hypertens 2013; 31: 1387-1395.
• Kawai T, Ohishi M, Onishi M, Ito N, Takeya Y, Maekawa Y, Rakugi H.
• Cut-off Value of Brachial-ankle Pulse Wave Velocity to Predict Cardiovascular Disease in Hypertensive Patients: A Cohort Study.
  J Atheroscler Thromb 2013; 20: 391-400.
• Kawai T, Ohishi M, Kamide K, Nakama C, Onishi M, Ito N, Takami Y, Takeya Y, Rakugi H.
• Differences between daytime and night-time blood pressure variability regarding systemic atherosclerotic change and renal function.
  Hypertens Res 2013; 36: 232-239.
• Kawai T, Kamide K, Ito N, Onishi M, Oguro R, Takeya Y, Tatara Y, Maekawa Y, Katsuya T, Ohishi M, Rakugi H.
• -374 T/A polymorphism in receptor of advanced glycation end product (RAGE) gene is associated with onset of diabetes mellitus, atherosclerosis, and renal dysfunction in patients with hypertension.
  Clin Exp Hypertens 2013; 35: 236-241.
• Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Yamamoto K, Oguro R, Kamide K, Rakugi H.
• Adioponectin single nucleotide polymorphism is a genetic risk factor for stroke through high pulse wave pressure: a cohort study.
  J Atheroscler Thromb 2013; 20: 152-160.
• Takeda M, Yamamoto K, Takemura Y, Takeshita H, Hongyo K, Kawai T, Hanasaki-Yamamoto H, Oguro R, Takami Y, Tatara Y, Takeya Y, Sugimoto K, Kamide K, Ohishi M, Rakugi H.
• Loss of Angiotensin-converting enzyme 2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice.
  Diabetes 2013; 62: 223-233.
• Fukutomi M, Tanaka N, Uchinoumi H, Kanemoto M, Nakao F, Yamada J, Kamei T, Takenaka T, Fujii T.
• Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P.
  J Cardiol 2013; 62: 63-69.
• Nakahara M, Ito T, Kawahara KI, Yamamoto M, Nagasato T, Shrestha B, Yamada S, Miyauchi T, Higuchi K, Takenaka T, Yasuda T, Matsunaga A, Kakihana Y, Hashiguchi T, Kanmura Y, Maruyama I.
• Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism.
  PLoS One 2013; 8: e75961.
• Suenaga M, Yamamoto M, Tabata S, Itakura S, Miyata M, Hamasaki S, Furukawa T.
• Influence of gefitinib and erlotinib on apoptosis and c-MYC expression in H23 lung cancer cells.
  Anticancer Res 2013; 33: 1547-1554.
• Matsushima S, Kuroda J, Ago T, Zhai P, Ikeda Y, Oka S, Fong GH, Tian R, Sadoshima J.
• Broad suppression of NADPH oxidase activity exacerbates ischemia/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1α and upregulation of peroxisome proliferator-activated receptor-α.
  Circ Res 2013, 12; 112:1135-49.
• Hariharan N, Ikeda Y, Hong C, Alcendor RR, Usui S, Gao S, Maejima Y, Sadoshima J.
• Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart.
  PLoS One 2013; 8: e51632.
• Yuasa T, Takasaki K, Mizukami N, Ueya N, Kubota K, Horizoe Y, Chaen H, Kuwahara E, Kisanuki A, Hamasaki S.
• Prosthetic tricuspid valve dysfunction assessed by three-dimensional transthracic and transesophageal echocardiography.
  J Echocardiogr 2013; 11: 97-99.
• Ichiki T, Boerrigter G, Huntley BK, Sangaralingham SJ, McKie PM, Harty G, Harders EG, Burnett JC, Jr.
• Differential Expression of the Pro-natriuretic Peptide Convertases Corin and Furin in Experimental Heart Failure and Atrial Fibrosis.
  Am J Physiol Regul Integr Com Physiol 2013;304:R102-9.
• Ichiki T, Izumi R, Cataliotti A, Larsen AM, Sandberg SM, Burnett JC, Jr.
• Endothelial Permeability in vitro and in vivo: Protective actions of ANP and Omapatrilat in Experimental Atherosclerosis.
  Peptides 2013;48C:21-26.
• McKie PM, Cataliotti A, Ichiki T, Sangaralingham SJ, Chen HH, Burnett, JC, Jr.
• M-Atrial Natriuretic Peptide and Nitroglycerin in Experimental Acute Hypertensive Heart Failure: Differential Actions of Two cGMP Activating Therapeutics.
  J Am Heart Assoc 2013 (in press)
• Tokito A, Jougasaki M, Ichiki T, Hamasaki S.
• Cardiotrophin-1 induces Matrix Metalloproteinase-1 in Human Aortic Endothelial Cells.
  PLoS ONE 2013;8:e68801.
• Ichiki H, Oketani N, Ishida S, Iriki Y, Okui H, Maenosono R, Namino F, Ninomiya Y, Miyata M, Hamasaki S, Tei C.
• The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.
  Pacing Clin Electrophysiol 2013; 36: 1328-1335.
• Akasaki Y, Ouchi N, Izumiya Y, Bernardo BL, LeBrasseur NK, Walsh K.
• Glycolytic fast-twitch muscle fiber restoration counters adverse age-related changes in body composition and metabolism.
  Aging Cell 2013; DOI:10.1111/acel.12153.
• Yoshino S, Yoshikawa A, Hamasaki S, Ishida S, Oketani N, Saihara K, Okui H, Kuwahata S, Fujita S, Ichiki H, Ueya N, Iriki Y, Maenosono R, Miyata M, Tei C.
• Atrial fibrillation-induced endothelial dysfunction improves after restoration of sinus rhythm.
  Int J Cardiol 2013; 168: 1280-1285.
• Matsuo Y, Cassar A, Yoshino S, Flammer AJ, Li J, Gulati R, Topilsky Y, Raichlin E, Lennon RJ, Lerman LO, Rihal CS, Kushwaha SS, Lerman A.
• Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation.
  J Heart Lung Transplant 2013; 32: 784-791.
• Nakahara M, Ito T, Kawahara K, Yamamoto M, Nagasato T, Shrestha B, Yamada S, Miyauchi T, Higuchi K, Takenaka T, Yasuda T, Matsunaga A, Kakihana Y, Hashiguchi T, Kanmura Y, Maruyama I.
• Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism.
  PloS One 2013 Sep 30; 8:e75961.doi:10.1371/ journal.pone.0075961.
• Kajiya T, Er BH, Chan MY, Low AF, Tan HC, Tai BC, Lee CH.
• Paradoxical effects of adiponectin level on plaque vulnerability and clinical outcomes after coronary revascularization.
  Int J Cardiol 2013; 168: 4796-4798.
• Kajiya T, Liang M, Sharma RK, Lee CH, Chan MY, Tay E, Chan KH, Tan HC, Low AF.
• Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI).
  EuroIntervention 2013; 9: 501-504.
• Kajiya T, Sethi R, Liang M, Chan MY, Lee CH, Chan KH, Tan HC, Low AF.
• Practice patterns, feasibility and efficacy of percutaneous coronary interventions (PCI) using small French size vascular access.
  Int J Cardiol 2013; 168: 4287-4288.
• Kajiya T, Agahari F, Lay wai K, Tai BC, Lee CH, Chan KH, Teo SG, Richards AM, Tan HC, Low AF, Chan MY.
• A Single-Centre Experience of Transitioning from a Routine Transfemoral to a Transradial Intervention Approach in ST-Elevation Myocardial Infarction: Impact on Door-to-Balloon Time and Clinical Outcomes.
  J Cardiol 2013; 62: 12-17.
• Kajiya T, Liang M, Chan KH.
• Percutaneous coronary intervention (PCI) to a right coronary artery with giant coronary fistula.
  Cath Lab Digest 2013; 21: 42-43.
• Liang M, Kajiya T, Lee CH, Chan M, Teo SG, Chan KH, Tan HC, Low AF.
• Initial experience in the clinical use of everolimus-eluting bioresorbable vascular scaffold (BVS) in a single institution.
  Int J Cardiol 2013; 168: 1536-1537.
• Hein T, Loo G, Ng YE, Tai BC, Kajiya T, Tan A, Khoo SM, Chan M, Low AF, Chia BL, Richards M, Lee CH.
• Relationship between Apnoea-Hypopnoea Index and Angiographic Coronary Disease Phenotypes in Patients Presenting with Acute Myocardial Infarction.
  Acute Card Care 2013; 15: 26-33.
• Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Tei C, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T.
• Influence of initial acute myocardial infarction presentation on the outcome of surgical procedures after coronary stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2.
  Cardiovasc Interv Ther 2013; 28: 45-55.
• Ben-Shlomo Y, Spears M, Boustred C, May M, Simon GA, Benjamin EJ, Boutouyrie P, Cameron J, Chen CH, Cruickshank JK, Hwang SJ, Lakatta EG, Laurent S, Maldonado J, Mitchell GF, Najjar SS, Newman AB, Ohishi M, Pannier B, Pereira T, Ramachandran VS, Shokawa T, Sutton-Tyrell K, Verbeke F, Wang KL, Webb DJ, Hansen TW, Zoungas S, McEniery CM, Cockcroft JR, Wilkinson IB.
• Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects.
  J Am Coll Cardiol (in press)
• Wang X, Sugimoto K, Fujisawa T, Shindo N, Minato S, Kamada Y, Hamano M, Ohishi M, Ikegami H, Rakugi H.
• Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse.
  Hepatol Res (in press)
• Kawai T, Ohishi M, Takeya Y, Onishi M, Ito N, Oguro R, Yamamoto K, Kamide K, Rakugi H.
• Carotid Plaque Score and Intima Media Thickness as Predictors of Stroke and Mortality in Hypertensive Patients.
  Hypertens Res (in press)
• Yoshino S, Cassar A, Matsuo Y, Herrmann J, Gulati R, Prasad A, Lennon RJ, Lerman LO, Lerman A.
• Relationship between fractional flow reserve with dobutamine challenge and coronary microvascular endothelial dysfunction in symptomatic myocardial bridging.
  Circ J 2013 (in press)